MXPA05002826A - Procedimiento para fabricar cristales de hormona de crecimiento. - Google Patents
Procedimiento para fabricar cristales de hormona de crecimiento.Info
- Publication number
- MXPA05002826A MXPA05002826A MXPA05002826A MXPA05002826A MXPA05002826A MX PA05002826 A MXPA05002826 A MX PA05002826A MX PA05002826 A MXPA05002826 A MX PA05002826A MX PA05002826 A MXPA05002826 A MX PA05002826A MX PA05002826 A MXPA05002826 A MX PA05002826A
- Authority
- MX
- Mexico
- Prior art keywords
- crystals
- functional derivatives
- growth hormone
- manufacturing
- propanol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormones [GH] (Somatotropin)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH] (Somatotropin)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Endocrinology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Se provee un procedimiento para fabricar cristales de hormona de crecimiento (GH), o derivados funcionales de la misma, que comprende los siguientes pasos: (a) preparar una solucion acuosa de GH, o derivados funcionales de la misma, que comprenda 2-propanol, (b) incubar la solucion preparada en el paso (a) para cristalizar dicha GH, o derivados funcionales de la misma, y (c) aislar los cristales formados en el paso (b); se provee tambien un uso novedoso de 2-propanol como un agente de cristalizacion para fabricar cristales de GH, o derivados funcionales de la misma; ademas, se proveen cristales obtenibles mediante el procedimiento y las composiciones farmaceuticas que comprenden los cristales; los cristales son utiles como un medicamento, en la fabricacion de dicho medicamento, y en un metodo para tratar a un mamifero, incluyendo un humano.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0202719A SE0202719D0 (sv) | 2002-09-13 | 2002-09-13 | Process for mfg crystals of growth hormone |
| PCT/SE2003/001422 WO2004024753A1 (en) | 2002-09-13 | 2003-09-12 | Process for manufacturing crystals of growth hormone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA05002826A true MXPA05002826A (es) | 2005-09-30 |
Family
ID=20288983
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA05002826A MXPA05002826A (es) | 2002-09-13 | 2003-09-12 | Procedimiento para fabricar cristales de hormona de crecimiento. |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1539797A1 (es) |
| JP (1) | JP2006513986A (es) |
| AU (1) | AU2003259002A1 (es) |
| BR (1) | BR0314187A (es) |
| CA (1) | CA2498525A1 (es) |
| MX (1) | MXPA05002826A (es) |
| SE (1) | SE0202719D0 (es) |
| WO (1) | WO2004024753A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5148635B2 (ja) * | 2007-03-05 | 2013-02-20 | ロディア オペレーションズ | 物質の結晶化を追跡する方法と対応する微小流体装置およびスクリーニング方法 |
| GB201409451D0 (en) | 2014-05-28 | 2014-07-09 | Ipabc Ltd | Antimicrobial preparations, methods for preparing the same and uses thereof to combat microorganisms |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5130298A (en) * | 1989-05-16 | 1992-07-14 | Ethicon, Inc. | Stabilized compositions containing epidermal growth factor |
| US5109117A (en) * | 1990-06-26 | 1992-04-28 | Monsanto Company | Method of somatotropin naturation using urea and a soluble organic alcohol |
| DK168790D0 (es) * | 1990-07-13 | 1990-07-13 | Novo Nordisk As | |
| US5849704A (en) * | 1991-12-20 | 1998-12-15 | Novo Nordisk A/S | Pharmaceutical formulation |
| SE9302278D0 (sv) * | 1992-10-28 | 1993-07-02 | Kabi Pharmacia Ab | Growth hormone |
| JP3723857B2 (ja) * | 1998-02-04 | 2005-12-07 | 日本ケミカルリサーチ株式会社 | ヒト成長ホルモン含有水性医薬組成物 |
-
2002
- 2002-09-13 SE SE0202719A patent/SE0202719D0/xx unknown
-
2003
- 2003-09-12 EP EP03795535A patent/EP1539797A1/en not_active Ceased
- 2003-09-12 MX MXPA05002826A patent/MXPA05002826A/es not_active Application Discontinuation
- 2003-09-12 JP JP2004535333A patent/JP2006513986A/ja not_active Withdrawn
- 2003-09-12 AU AU2003259002A patent/AU2003259002A1/en not_active Abandoned
- 2003-09-12 WO PCT/SE2003/001422 patent/WO2004024753A1/en active Search and Examination
- 2003-09-12 BR BR0314187-0A patent/BR0314187A/pt not_active IP Right Cessation
- 2003-09-12 CA CA002498525A patent/CA2498525A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003259002A1 (en) | 2004-04-30 |
| BR0314187A (pt) | 2005-08-09 |
| SE0202719D0 (sv) | 2002-09-13 |
| EP1539797A1 (en) | 2005-06-15 |
| WO2004024753A1 (en) | 2004-03-25 |
| JP2006513986A (ja) | 2006-04-27 |
| CA2498525A1 (en) | 2004-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003216879A1 (en) | Method for producing c13-alcohol mixtures | |
| WO2005106090A3 (en) | Preform produced by electrospinning, method for producting the same and use of such a preform | |
| WO2005065185A3 (en) | Temperature-stable formulations, and methods of development thereof | |
| MXPA05008489A (es) | Procedimiento de fabricacion para preparaciones liposomicas. | |
| WO2002066477A3 (en) | Imidazopyridines | |
| AU2003258621A1 (en) | Novel purine derivatives, production and use thereof as medicaments | |
| TW200637839A (en) | 1-thio-d-glucitol derivatives | |
| WO2004037789A3 (en) | Methylene urea derivatives as raf-kinase inhibitors | |
| ATE544445T1 (de) | Herstellung von sterilen wässrigen suspensionen mit mikronisierten kristallinen wirkstoffen zur inhalation | |
| HK1066545A1 (en) | Novel amlodipine camsylate and method for preparing thereof | |
| YU94103A (sh) | Novi derivati sulfonske kiseline | |
| WO2002009639A3 (en) | Methods and pharmaceutical compositions for healing wounds | |
| EP1594885B8 (de) | Medikament zur wachstumsinhibierung von tumoren | |
| ATE299144T1 (de) | Verfahren zur herstellung einer pharmazeutisch aktiven verbindung (granisetron) | |
| DE50301559D1 (de) | Verfahren zur herstellung von tocotrienol-angereicherten präparationen | |
| MXPA05002826A (es) | Procedimiento para fabricar cristales de hormona de crecimiento. | |
| BR0317665A (pt) | 1-alquil-3-aminoindazóis | |
| WO2007052308A3 (en) | Glyco-phosphorylated biologically active agents | |
| WO2004009608A3 (en) | Novel amorphous 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a, process for preparing the same, and use thereof | |
| CA2449769A1 (en) | S-omeprazole (esomeprazole) inclusion complex with cyclodextrins | |
| AU726662B2 (en) | Solid compound, its preparation and use in medicine | |
| JP2004536810A5 (es) | ||
| WO2002092565A3 (en) | 3-aminoalkyl-2-aryl-indole derivatives and their use as gnrh antagonists | |
| PT1218401E (pt) | 4-benzilaminoquinolinas conjugadas com acido biliar e seus heterociclicos metodos de sua producao medicamentos contendo estes compostos e sua aplicacao | |
| CA2402364A1 (en) | Process for producing camptothecin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |